JPMorgan maintained its Overweight rating on Mankind Pharma Ltd (MANKIND:IN) and increased the price target from INR3,000.00 ...

Mankind's revenue from operations rose to Rs 3,230 crore in Q3FY25, a 24 per cent Y-o-Y rise from Rs 2,607 crore reported in ...

Mankind Pharma Limited was incorporated on July 3, 1991, as a Private Limited Company with the name Mankind Pharma Private Limited, by the Registrar of Companies, Delhi and Haryana, at New Delhi.

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter ...

Macquarie has lowered its FY25/26/27 earnings estimates by 17 percent, 24 percent, and 17 percent, respectively, due to earnings dilution stemming from the BSV acquisition.

No Data For Bulk Deal. *Involves transaction of at least 0.5% of the listed shares of a company. What was Mankind Pharma Ltd share price previously? Mankind Pharma Ltd share price was down by -1. ...

The Board of Directors of Mankind Pharma Limited, at its meeting held today have approved the financial results of the ...

Net profit of mankind Pharma declined by 16.2% to ₹380.2 crore compared with ₹453.8 crore in the corresponding quarter of the previous year ...

The Nifty Pharma index closed on a positive note on Thursday. Shares of Abbott India Ltd.(up 4.61 per cent), Natco Pharma Ltd ...

Mankind Pharma Limited (Mankind), established in 1995, is a fast-growing pharmaceuticals and consumer healthcare company. It ...

Mankind Pharma's net profit fell 16.5% to Rs 384 crore in Q3 FY25, while revenue rose 24% to Rs 3,230 crore. The company's ...

Mankind Pharma's Q3 net profit was impacted by the $1.6 billion acquisition of Bharat Serums and Vaccines (BSV), which came ...